Ningyan Zhang

8.7k total citations · 3 hit papers
122 papers, 4.7k citations indexed

About

Ningyan Zhang is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ningyan Zhang has authored 122 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 40 papers in Oncology and 29 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ningyan Zhang's work include Monoclonal and Polyclonal Antibodies Research (28 papers), HER2/EGFR in Cancer Research (19 papers) and Cytomegalovirus and herpesvirus research (15 papers). Ningyan Zhang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (28 papers), HER2/EGFR in Cancer Research (19 papers) and Cytomegalovirus and herpesvirus research (15 papers). Ningyan Zhang collaborates with scholars based in United States, China and Japan. Ningyan Zhang's co-authors include Zhiqiang An, Xuejun Fan, Berne L. Jones, Xun Gui, Kyoji Tsuchikama, Yasuaki Anami, Wei Xiong, Tong‐Ming Fu, Chisato M. Yamazaki and Hui Deng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Neuron.

In The Last Decade

Ningyan Zhang

118 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function

2018 519 citations Yingjun Zhao, Xilin Wu et al. Neuron profile →
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

2021 210 citations Chisato M. Yamazaki, Aiko Yamaguchi et al. Nature Communications profile →
Human adipose-derived mesenchymal stem cells-derived exosomes encapsulated in pluronic F127 hydrogel promote wound healing and regeneration

2022 132 citations Ningyan Zhang et al. profile →

Peers

Countries citing papers authored by Ningyan Zhang

Since Specialization

Citations

This map shows the geographic impact of Ningyan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningyan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningyan Zhang more than expected).

Fields of papers citing papers by Ningyan Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningyan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningyan Zhang. The network helps show where Ningyan Zhang may publish in the future.

Co-authorship network of co-authors of Ningyan Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Ningyan Zhang. A scholar is included among the top collaborators of Ningyan Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningyan Zhang. Ningyan Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development 2025 ·Cancer Immunology Research ·(unknown), (unknown), (unknown), Mi Deng, Xiaoye Liu, Ryan Huang, (unknown), (unknown), (unknown), (unknown), Caroline Smith, Samuel John, Wei Xiong, Xin Li, Cheryl Lewis, Jade Homsi, Ankit Gupta, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang	1
2	Secretogranin 2 binds LILRB4 resulting in immunosuppression 2025 ·Nature Immunology ·Xiaofeng Yang, (unknown), (unknown), (unknown), Jingjing Xie, Xiaoye Liu, Cheng Cheng Zhang, (unknown), (unknown), Wei Xiong, Cheryl Lewis, (unknown), Ankit Gupta, (unknown), Xuewu Zhang, Lei Guo, Lin Xu, Ningyan Zhang, Zhiqiang An	3
3	Serum endotrophin relates to blood pressure in young South Asian women but not White women: evidence of ethnic variation in its early vascular implications 2025 ·BMC Cardiovascular Disorders ·Ravi Retnakaran, Dawei Bu, (unknown), Philip W. Connelly, Anthony J. Hanley, Ningyan Zhang, Zhiqiang An, Bernard Zinman, Philipp E. Scherer	0
4	SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies 2024 ·Viruses ·Hailong Guo, Sha Ha, Jason Botten, Kai Xu, Ningyan Zhang, Zhiqiang An, William R. Strohl, John W. Shiver, Tong‐Ming Fu	6
5	Fc gamma receptors promote antibody-induced LILRB4 internalization and immune regulation of monocytic AML 2023 ·PubMed ·Joshua Morse, Xun Gui, Mi Deng, Ryan Huang, Xiaohua Ye, Peng Zhao, Xuejun Fan, Wei Xiong, Cheng Cheng Zhang, Ningyan Zhang, Zhiqiang An	3
6	Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets 2023 ·Expert Opinion on Investigational Drugs ·Joshua Morse, (unknown), (unknown), Adan Rios, Cheng Cheng Zhang, Naval Daver, Courtney D. DiNardo, Ningyan Zhang, Zhiqiang An	5
7	An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody–Drug Conjugates 2022 ·Molecular Cancer Therapeutics ·Summer Y.Y. Ha, Yasuaki Anami, Chisato M. Yamazaki, Wei Xiong, (unknown), Scott D. Olson, Jangsoon Lee, Naoto T. Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama	36
8	Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma 2022 ·PLoS ONE ·Jingbo Qiao, Junquan Liu, (unknown), Rachael A. Clark, Sora Lee, Li Liu, Zhiqiang An, Ningyan Zhang, Dai H. Chung	5
9	A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer’s disease 2022 ·Science Translational Medicine ·Peng Zhao, Yuanzhong Xu, Lu-Lin Jiang, Xuejun Fan, Leike Li, Xin Li, Hisashi Arase, Yingjun Zhao, Wei Cao, Hui Zheng, Huaxi Xu, Qingchun Tong, Ningyan Zhang, Zhiqiang An	92
10	Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies 2022 ·Science Advances ·Daniel Wrapp, Xiaohua Ye, Zhiqiang Ku, Hang Su, (unknown), Nianshuang Wang, (unknown), Daniel C. Freed, Fengsheng Li, Aimin Tang, Leike Li, Dabbu Kumar Jaijyan, (unknown), Dai Wang, Tong‐Ming Fu, Ningyan Zhang, Zhiqiang An, Jason S. McLellan	17
11	Inhibition of astrocyte hemichannel improves recovery from spinal cord injury 2021 ·JCI Insight ·Chao Zhang, (unknown), (unknown), Manuel A. Riquelme, Sumin Gu, (unknown), David J. Wallace, Viktor Bartanusz, (unknown), Wei Xiong, Ningyan Zhang, Michael Mader, Zhiqiang An, N. Sayre, Jean X. Jiang	27
12	Serum levels of endotrophin are associated with nonalcoholic steatohepatitis 2021 ·Scandinavian Journal of Gastroenterology ·Hannes Hagström, Dawei Bu, Patrik Nasr, Mattias Ekstedt, (unknown), Stergios Kechagias, Ningyan Zhang, Zhiqiang An, Per Stål, Philipp E. Scherer	9
13	Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope 2021 ·Bioorganic & Medicinal Chemistry ·Aiko Yamaguchi, Yasuaki Anami, Summer Y.Y. Ha, (unknown), Wei Xiong, Jangsoon Lee, Naoto T. Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama	16
14	Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance breakdown → 2021 ·Nature Communications ·Chisato M. Yamazaki, Aiko Yamaguchi, Yasuaki Anami, Wei Xiong, Yoshihiro Otani, Jangsoon Lee, Naoto T. Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama	210
15	Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection 2020 ·Virology ·(unknown), (unknown), (unknown), Jennifer A. Jenks, Cody S. Nelson, (unknown), (unknown), Sarah Valencia, Justin Pollara, W. Daniel Edwards, Jason S. McLellan, Daniel Wrapp, Tong‐Ming Fu, Ningyan Zhang, Daniel C. Freed, Dai Wang, Zhiqiang An, Sallie R. Permar	12
16	Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib 2019 ·SHILAP Revista de lepidopterología ·Zhenhai Gao, Chun Song, Li G, Ho Lin, Xin Lian, Ningyan Zhang, (unknown)	3
17	Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes 2019 ·PLoS Pathogens ·Leike Li, Weixu Meng, Melanie Horton, (unknown), Elizabeth Thoryk, Jennifer M. Pfaff, Qihui Wang, Georgina To’a Salazar, Trevor Barnes, Benjamin J. Doranz, Andrew J. Bett, Danilo R. Casimiro, Kalpit A. Vora, Zhiqiang An, Ningyan Zhang	30
18	Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo 2018 ·Breast Cancer Research ·(unknown), Xuejun Fan, Robert E. Jordan, Ningyan Zhang, Zhiqiang An	17
19	TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function breakdown → 2018 ·Neuron ·Yingjun Zhao, Xilin Wu, Xiaoguang Li, Lu-Lin Jiang, Xun Gui, Yan Liu, Yu Sun, Bing Zhu, Juan Piña-Crespo, Muxian Zhang, Ningyan Zhang, Xiaochun Chen, Guojun Bu, Zhiqiang An, Timothy Y. Huang, Huaxi Xu	519
20	Dysfunctional Antibodies in the Tumor Microenvironment Associate with Impaired Anticancer Immunity 2015 ·Clinical Cancer Research ·Ningyan Zhang, Hui Deng, Xuejun Fan, Anneliese Gonzalez, Songlin Zhang, Randall J. Brezski, Byung‐Kwon Choi, Michael A. Rycyzyn, William R. Strohl, Robert Jordan, Zhiqiang An	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact